Thomopoulou Konstantina

Thomopoulou Konstantina Internist Oncologist

5th Medical Oncology Department, Hygeia Hospital

Education & Academic Qualifications

  • 02/2018- Present: PhD student: Laboratory of Translational Oncology, School of Medicine, Heraklion, CreteBreast Cancer Research and Immuno-oncology  MRCP UK PART1: PASS -5/2016
  • 10/2010 – 05/2012: MSc in “Thoracic Oncology: Current Clinical and Molecular Approach & Research” National & Kapodistrian University of Athens, Greece
  • 10/2004 – 07/2010: MBChB in Medicine, Democritus University of Thrace, Greece DUTH

Work Experience

  • 4/2020-present: Assistant, 1st Medical Oncology Department, HYGEIA Hospital, Athens, Greece

  • 1/2017-3/2020: Residency in Medical oncology with medical on-call duties, University Hospital of Heraklion, Greece

  • 8/2015-8/2016: Specilaty Training 1/2 Trust hematology with medical on-call duties, Broomfield Hospital NHS Mid Essex

  • 09/2014-04/2015: Clinical Fellow in Medical Oncology, NHS Beatson Hospital, Glasgow

  • 08/2012 – 08/2014: Internal Medicine Unit – General Hospital of Ksanthi, Greece

  • 01/2012-05/2012: Post graduate Scholarship in medical capacity, Oncology Unit- Hygeia Hospital, Athens, Greece

  • 12/2010-12/2011: Rural Obligatory position(agrotiko), Kalavrita Hospital

Education Experience

  • 04/2011: 23th National conference of General Medicine, Kos Greece

Talk presentantion: The side effects of diphosphonates in the oral cavity

Talk presentantion:Pre-symptomatic control of colon cancer: public opinion 

  • 17-19/11/2017:9th seminar of Clinical Oncology –Thesaloniki,Greece

Talk presentation: metastatic breast cancer,brca mutation ,different disease ?

  • 23-26/11/2017: Conference of clinical and translational oncology

Case presentation: neoadjuvant treatment on rectal cancer 

  • 14-16/11/2018: Conference of clinical and translational oncology, Heraklion, Crete,Greece

  • Talk presentation: Case of a patient with BRCA mutant TNBCTalk presentation: 2 cases of metastatic adenocarcinoma with high PDL1 expression

  • 2329/3/2019: 18th ESO-ESMO Masterclass in Clinical Oncology , Lodgut Sober, Germany,presentation of a case report (breast cancer)

  • 2nd School of Clinical Immunology, Heraklion, Crete, 2019, presentation to students and clinicians of a case with thymoma that received pembrolizumab.

  • 4/7/2020: American Association of Cancer Research in collaboration with European platform for cancer research, Methods in Clinical Research workshop, selected for talk presentation of the research idea: phase I trial of ribociclib –nivolumab-canakimumab, trial design.

  • 11/7/2020: Panhellenic Oncology Conference, talk on: Immunotherapy toxicity management, and its continuation in patients with response

Clinical & Research Interest

Clinical Interest:

  • Breast cancer 

  • Lung Cancer

  • Gynecological Malignancies

  • Head&Νeck cancer, Thyroid Cancer

  • Gastrointestinal cance

  Research Interest:

  • Translation Research

  • Breast cancer

  • Head&Neck cancer

  • Lung Cancer

Honors & Awards

National Board Examination in Medical Oncology, Greece (2/2020)

Best poster presentation. 7/2020, Panhellenic Oncology Congress. E-poster theme: microrna’s regulating immune cell interactions in the prediction of early relapse in breast cancer (1st author)

Travel award: 4th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers 2019, Milan, Italy

ESMO-Certification in Medical Oncology, September 2019 (ESMO EXAMINATION)

Travel award: 18th ESO-ESMO Masterclass in Clinical Oncology 2019, Berlin, Germany

Travel award: Esmo Oxford Academy 2018, Oxford, UK

Hygeia Hospital, Athens, Greece 4 months scholarship for post-graduate studies (02/12-5/12).

Recent Publications

Chara Papadaki, Konstantina Thomopoulou, George Koronakis et al. MicroRNAs involved in immune response as prognostic markers in early and metastatic breast cancer.Journal of Clinical Oncology 2020 38:15_suppl, e15528-e15528

Konstantina T, Konstantinos R, Anastasios K, et al. Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review. Lung Cancer. 2019;135:29-32. doi:10.1016/j.lungcan.2019.06.015

K Thomopoulou, M Tzardi, D Mavroudis, J Souglakos, A case presentation of a patient with microsatellite instability and BRAF mutant metastatic colon cancer and bibliography update, Case reports in Oncological Medicine ,2019, Article ID 4767019, 5 pages

Konstantina Thomopoulou, Chara Papadaki, Alexia Monastirioti et al. microRNAs regulating tumor and immune cell interactions in the prediction of early relapse in breast cancer [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P1-05-07.

Konstantina Thomopoulou, Stavroula Manolakou, Ippokratis Messaritakis, Maria Tzardi, Eleni Lagoudaki3, Anastasios Koutsopoulos, Andreas Koulouris, George Kanellis, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos, Brain and bone metastases from rectal cancer, Ann Gastroenterol, 2020 Jan-Feb;33(1):95-97. doi: 10.20524/aog.2019.0423. Epub 2019 Oct 8.

Maria A Papadaki, Anastasios V Koutsopoulos, Eleni Lagoudaki, Alexia Monastirioti, Konstantina Thomopoulou et al. Comparative analysis of PD-L1 expression on matched primary tumors, metastasis and peripheral blood of patients with breast cancer [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P3-05-03.

Stylianos Zervakis, Nikolaos Spernovasilis, Erasmia Boutakoglou, Simeon Panagiotakis, Konstantina Thomopoulou, George Samonis, Erythroderma as a paraneoplastic manifestation of small cell lung cancer, Current problems in Cancer,2019, 100499

Sofia Agelaki, Maria A. Papadaki, Panormitis G Tsoulfas, Despoina Aggouraki, Alexia A Monastirioti, Katerina A Merodoulaki, Konstantina Thomopoulou,Chara Papadaki, Dimitrios Mavroudis, Role of the expression of PD-L1 and CD47 on circulating tumor cells (CTCs) in the prediction of outcome in metastatic breast cancer (mBC) patients. Journal of Clinical Oncology, 37, no. 15_suppl,DOI: 10.1200/JCO.2019.37.15_suppl.e14045

Vassias A., Gkiozos I., Thomopoulou K., et al. Effects of Smoking Cessation on lung cancer chemotherapy. Tobacco Prevention & Cessation. 2017;3(May Supplement):63. doi:10.18332/tpc/70836.